Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences
Bank of America Merrill Lynch Healthcare Conference inLas Vegas, NV onWednesday, May 16, 2018 at8:40 a.m. PDT /4:40 p.m. IST .Bruce Cozadd , chairman and chief executive officer, will provide an overview of the company and a business and financial update.
UBS Global Healthcare Conference inNew York, NY onWednesday, May 23, 2018 at8:00 a.m. EDT /1:00 p.m. IST .Matt Young , executive vice president and chief financial officer, will provide an overview of the company and a business and financial update.
- Bernstein Annual
Strategic Decisions Conference inNew York, NY onFriday, June 1, 2018 at8:00 a.m. EDT /1:00 p.m. IST .Bruce Cozadd , chairman and chief executive officer, will provide an overview of the company and a business and financial update.
A live audio webcast of each presentation may be accessed from the Investors section of the
An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at http://www.jazzpharmaceuticals.com.
About
View original content with multimedia:http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-participation-in-three-upcoming-investor-conferences-300645720.html
SOURCE
Investors: Kathee Littrell, Vice President, Investor Relations, Ireland, +353 1 634 7887, U.S., +1 650 496 2717, or Media: Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations, Ireland, +353 1 697 2141, U.S., +1 215 867 4910